LUCIUS 卢修斯 艾乐替尼 Alectinib非小细胞肺癌

艾乐替尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Alectinib

老挝国家食药监局批准上市
老挝国家药检所检测认证

Composition:

Each capsule contains Alectinib HCT

LUCIUS

161.33 mg equivalent to Alectinib ... 150mg.

非小细胞肺癌

PHARMACEUTICALS

Indication:
LuciAle is a kinase inhibitor indicated for
the treatment of patients with anaplasti
lymphoma kinase (ALK)-positive
metastatic non-small cell lung cance
(NSCLC) as detected by an FDA-approved

LuciAle

test.

Dosage and Use:
600 mg orally twice daily. Administe

LuciAle with food

Alectinib Capsules

Storage: in a dry place and store at 20C t

FDA批准

25°C.

150mg

Keep medicine out of reach of Children. Do
not administer LuciAle during Pregnancy

and Lactation

PLEASE SEE PACKAGE INSERT

Rx Only

Manufactured and Marketed by:

LUCIUS

权威认证

Thongmang village, Xaythany district,
Vientiane Capital, Laos
www.lucius.la

Warning: To be sold by retail on prescription
ot regislered paysicians only, and as directed
by the physictan

56 Capsules

口碑质量

适应症:
适用于经FDA批准的检测方法检测为间变性淋巴瘤
激酶(ALK)阳性转移性非小细胞肺癌(NSCLC)患
者的治疗。
推荐剂量:
每日口服两次,每次600mg,随餐服用。